Epirubicin and Cyclophosphamide-induced Acute Fibrinous and Organizing Pneumonia

Am J Respir Crit Care Med. 2021 Oct 15;204(8):e92-e93. doi: 10.1164/rccm.202101-0020IM.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antibiotics, Antineoplastic / adverse effects*
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cryptogenic Organizing Pneumonia / chemically induced*
  • Cryptogenic Organizing Pneumonia / diagnostic imaging
  • Cryptogenic Organizing Pneumonia / pathology
  • Cyclophosphamide / adverse effects*
  • Epirubicin / adverse effects*
  • Fatal Outcome
  • Female
  • Humans
  • Middle Aged
  • Tomography, X-Ray Computed

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Alkylating
  • Epirubicin
  • Cyclophosphamide